|
|
||||||||
Published online before print April 13, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||







* Laboratory of Molecular Virology, Division of Emerging and Transfusion Transmitted Diseases, Office of Blood Research & Review, and
Laboratory of Immunobiochemistry, DBPAP, Office of Vaccine Research and Review, Center for Biologics Evaluation & Research, U.S. Food and Drug Administration, Rockville, Maryland;
Affymetrix, Santa Clara, California; and
Division of Monoclonal Antibodies, Office of Biotechnology Products, Center for Drug Evaluation and Research, Bethesda, Maryland
1Correspondence: Laboratory of Molecular Virology, Division of Emerging and Transfusion Transmitted Diseases, Office of Blood Research & Review, Center for Biologics Evaluation & Research, FDA, HFM 315, CBER, 1401 Rockville Pike, Rockville, MD 20852-1448. E-mail: Dayton{at}cber.fda.gov
We report a novel mechanism, involving up-regulation of the interleukin (IL)-7 cytokine receptor, by which human immunodeficiency virus (HIV) enhances its own production in monocyte-derived macrophages (MDM) in vitro. HIV-1 infection or treatment of MDM cultures with exogenous HIV-1 Tat(86) protein up-regulates the IL-7 receptor (IL-7R)
-chain at the levels of steady-state RNA, protein, and functional IL-7R on the cell surface (as measured by ligand-induced receptor signaling). This IL-7R up-regulation is associated with increased amounts of HIV-1 virions in the supernatants of infected MDM cultures treated with exogenous IL-7 cytokine. The overall effect of IL-7 stimulation on HIV replication in MDM culture supernatants is typically in the range of one log and greater. The results are consistent with a model in which HIV infection produces the Tat protein, which in turn up-regulates IL-7R in a paracrine manner. This results in increased IL-7R signaling in response to the IL-7 cytokine, which ultimately promotes early events in HIV replication, including binding/entry and possibly other steps prior to reverse transcription. The results suggest that the effects of IL-7 on HIV replication in MDM should be considered when analyzing and designing clinical trials involving treatment of patients with IL-7 or Tat vaccines.
Key Words: cytokine receptors cytokines Tat AIDS
This article has been cited by other articles:
![]() |
P. Kalantari, O. F. Harandi, P. A. Hankey, and A. J. Henderson HIV-1 Tat Mediates Degradation of RON Receptor Tyrosine Kinase, a Regulator of Inflammation J. Immunol., July 15, 2008; 181(2): 1548 - 1555. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |